This topic contains a solution. Click here to go to the answer

Author Question: Companies that are socially responsible to their investors do which of the following? A) provide ... (Read 160 times)

luvbio

  • Hero Member
  • *****
  • Posts: 623
Companies that are socially responsible to their investors do which of the following?
 
  A) provide appropriate information to shareholders and investors
  B) fail to use corporate resources judiciously
  C) thwart appropriate accounting procedures
  D) manipulate stock prices

Question 2

Which of the following is one of the main groups of stakeholders that firms usually focus on?
 
  A) competitors
  B) customers
  C) the government
  D) the general public



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

gcook

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

A

Answer to Question 2

B




luvbio

  • Member
  • Posts: 623
Reply 2 on: Jul 7, 2018
Great answer, keep it coming :)


jojobee318

  • Member
  • Posts: 298
Reply 3 on: Yesterday
Excellent

 

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library